Spinal Cord Stimulators Work for Neuropathic Pain but Fail for Low Back Pain—The Target Circuitry Determines Success

Spinal cord stimulation shows a split personality. For neuropathic pain, 60-86% of patients achieve at least 50% relief that lasts up to two years (PMC12731429). For chronic low back pain without leg involvement, Cochrane reviews find it no better than placebo. Same device, same implantation, completely different outcomes.

The mechanism explains the divergence.

Pain Relief: Dorsal Horn Inhibition

Traditional SCS targets the dorsal horn, where nociceptive signals first synapse. High-frequency modes at 10 kHz show 60-71% responder rates versus 40-47% for conventional stimulation (Pain Medicine, 2014). The electrical field suppresses wide-dynamic-range neurons, effectively closing the gate on pain transmission.

This works because the circuitry is relatively simple. Afferent fibers enter, synapse, ascend. The stimulator intercepts at a predictable point. The anatomy is consistent across patients.

Motor Recovery: A Different Problem Entirely

Epidural stimulation for spinal cord injury tells a more complex story. Spasticity drops in about 62% of patients. Voluntary movement returns in roughly 35% (PMID: 39211655). These numbers sound modest, but they represent recovery that was considered impossible a decade ago.

The mechanism here is not suppression—it is activation of dormant circuits. After incomplete SCI, motoneurons below the lesion become hyperactive, producing spasticity. Epidural stimulation at specific frequencies normalizes this hyperactivity, reducing Ashworth scores from 3 to 2-2.5 (p<0.02) (PMC11361623).

For voluntary movement, the stimulator acts as a bridge. It does not repair the cord. It amplifies residual descending signals that are too weak to trigger muscle activation on their own.

Why Low Back Pain Resists Treatment

Chronic low back pain without radiculopathy likely involves multiple circuits—dorsal horn, central sensitization, descending modulation, possibly supraspinal reorganization. SCS targets only the spinal component. When the pain generator lives elsewhere, spinal modulation has limited effect.

The Emerging Precision

Recent work suggests we have been thinking about parameters wrong. Combined burst (40 Hz) and tonic (60 Hz) modes simultaneously address pain and spasticity (PMID: 39211655). Cervical epidural stimulation produces pronounced upper extremity effects, with burst/tonic combinations outperforming single modes (Frontiers in Systems Neuroscience, 2025).

Cervical stimulation even heightened consciousness in 18% of traumatic brain injury patients, suggesting the electrical field engages supraspinal networks, not just spinal circuits (PMC11361623).

The Safety Reality

Benefits come with substantial risk. The FDA logged over 100,000 adverse events including 428 deaths over four years. Ten to twenty percent of devices are explanted due to complications or loss of efficacy.

The Hypothesis

SCS efficacy depends on matching stimulation parameters to the specific neural circuitry driving the symptom. Neuropathic pain responds because the generator is spinal and the target is accessible. Low back pain often fails because the generator is distributed. Motor recovery in SCI requires precise frequency tuning to normalize hyperactive motoneurons without masking residual descending signals.

The future is not better electrodes. It is closed-loop systems that detect the underlying neural state and adjust parameters in real time. When the stimulator responds to the nervous system rather than firing blindly, outcomes should improve across all indications.

Research synthesis via Aubrai.